Evidence map›Paper›PMID 36528379›Full record

ReviewLancet (London, England)2022

A call to accelerate an end to human rabies deaths.

S M Thumbi, Lucille Blumberg, Kevin le Roux, Naseem Salahuddin, Bernadette Abela

Abstract readReview
In one paragraph

Review in Lancet (London, England), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Zero by 30 and microarray patches.The Lancet regional health. Southeast Asia · 2024
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

S M ThumbiCenter for Epidemiological Modelling and Analysis, University of Nairobi, Nairobi, Kenya; Institute of Immunology and Infection Research, University of Edinburgh, Edinburgh, UK; Paul G Allen School for Global Health, Washington State University, Pullman, WA, USA. Electronic address: thumbi.mwangi@wsu.edu.
Lucille BlumbergRight to Care, Centurion, South Africa; Faculty of Veterinary Science, University of Pretoria, Tshwane, South Africa.
Kevin le RouxEpidemiology Unit, Veterinary Services, Department of Agriculture and Rural Development, KwaZulu-Natal, South Africa; South African Rabies Advisory Group, Pretoria, South Africa.
Naseem SalahuddinFaculty of Medicine and Infectious Diseases, Indus Hospital and Health Network, Karachi, Pakistan.
Bernadette AbelaDepartment of the Control of Neglected Tropical Diseases, WHO, Geneva, Switzerland.

Funding

Wellcome Trust 110330/Z/15/ZWorld Health Organization 001
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Dog DiseasesRabiesRabies VaccinesAnimalsDogsHumansRisk FactorsRabies Vaccines

Identifiers

PMID36528379
PMCPMC9754655

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.